Hodgkin's lymphoma mortality in the Americas, 1997–2008: Achievements and persistent inadequacies. Issue 3 (25th February 2013)

• Record Type: Journal Article
• Authors: Chatenoud, Liliane; Bertuccio, Paola; Bosetti, Cristina; Rodriguez, Teresa; Levi, Fabio; Negri, Eva; Vecchia, Carlo La
• Is Part Of: International journal of cancer. Volume 133:Issue 3(2013:Aug. 01)
• Page Start: 687
• Page End: 694
• Publication Date: 2013-02-25
• Subjects: cancer -- Hodgkin's lymphoma -- trends -- Latin America -- mortality; Cancer -- Periodicals; Cancer -- Prevention -- Periodicals; 616.994
• DOI: 10.1002/ijc.28049
• Languages: English
• ISSNs: 0020-7136

Abstract

Abstract : Although therapeutic advancements have made Hodgkin's lymphoma (HL) a largely curable disease, trends in HL mortality have been variable across countries. To provide updated information on HL mortality in the Americas, overall and 20–44 years age‐standardized (world population) mortality rates from HL were derived for the 12 Latin American countries providing valid data to the World Health Organization database and with more than two million of inhabitants. For comparative purpose, data for the United States and Canada were also presented. Trends in mortality over the 1997 to 2008 period are based on joinpoint regression analysis. Declines in HL mortality were registered in all Latin American countries except in Venezuela. In most recent years, HL mortality had fallen to about 0.3/100, 000 men and 0.2/100, 000 women in Argentina, Brazil, Chile, Colombia, Ecuador and Guatemala, that is, to values similar to North America. Despite some declines, rates remained high in Cuba (1/100, 000 men and 0.7/100, 000 women), Costa Rica and Mexico as well as in Venezuela (between 0.5 and 0.6/100, 000 men and between 0.3 and 0.5/100, 000 women). In young adults, trends were more favorable in all Latin American countries except Cuba, whose rates remained exceedingly high (0.8/100, 000 men and 0.6/100, 000 women). Thus, appreciable declines in HL mortality were observed in most Latin America over the last decade, and several major countries reached values comparable to North America. Substantial excess mortality was still observed in Cuba, Costa Rica, Mexico and Venezuela, calling for urgent interventions to improve HL management in these countries. Abstract : What's new? Mortality from Hodgkin's lymphoma differs between developed and less‐developed regions of the world, with mortality rates having declined markedly in the former but less so in the latter. In this study of Hodgkin's lymphoma mortality in 12 Latin American countries, selected based on population size and completeness of mortality data, appreciable declines were registered for the period 1997–2008 in most of the countries assessed, with rates reaching those observed in North America. However, substantial excesses remained in Cuba, Mexico, and Venezuela, calling for urgent intervention in these middle‐income countries.